|
Nitrosamine Impurity Test Market expected to grow exponentially by 2029
|
|
0
|
588
|
November 19, 2023
|
|
Nitrosamines in Bacon: a Case Study of Balancing Risks
|
|
1
|
300
|
March 20, 2024
|
|
NEWS! New USP Community on qNMR
|
|
0
|
371
|
March 1, 2024
|
|
Quality Officer Call for a New approach to Reduce Post Approval Complexity
|
|
0
|
294
|
February 28, 2024
|
|
๐ฐ Nitrosamine measures might disrupt anesthetic supply, Dr. Eric Tichy says
|
|
4
|
544
|
January 26, 2024
|
|
FDA leaders detail reorg plans Webinar
|
|
0
|
291
|
January 23, 2024
|
|
๐ช๐บ Ph. Eur. Commission adopts revised general monographs 2034 and 2619 after inclusion of new paragraph on control of N-nitrosamines
|
|
1
|
946
|
January 22, 2024
|
|
Reflective Beginnings: We have to be in the driver's seat
|
|
4
|
561
|
January 9, 2024
|
|
๐จโ๐ป Nitrosamines Trends in Google
|
|
0
|
456
|
January 8, 2024
|
|
๐ Happy Holiday and a Nitrosamines-free 2024!
|
|
8
|
822
|
January 7, 2024
|
|
ISP (Chile) announced the voluntary market withdrawal of Atomoxetine DP (40mg & 80mg) due presence of Nitroso-Atomoxetine
|
|
5
|
1497
|
December 14, 2023
|
|
ๅ
ณไบ2023่ฏ็ฉๆ่ดจๆงๅถๅฝ้
ไบคๆตไผ็่ต่ฎฏ
|
|
1
|
484
|
September 29, 2023
|
|
Singapore: HSA issues retail-level recalls for batches of Apo-Amitriptyline and Apo-Acyclovir tablets due to nitrosamine impurity concerns
|
|
0
|
601
|
September 4, 2023
|
|
Apotex Inc. Canada is recalling one lot of APO-Amitriptyline due to presence of nitrosamine impurity, N-nitrosodimethylamine (NDMA) above the acceptable limit at the 48-month stability testing timepoint
|
|
15
|
1536
|
September 3, 2023
|
|
Fluoxetin Recall - Austria
|
|
6
|
803
|
July 28, 2023
|
|
European Pharmacopoeia Commission revises position on nitrosamine impurities
|
|
2
|
632
|
July 28, 2023
|
|
๐ง๐ท ANVISA (Brasil) denies registration
|
|
0
|
500
|
July 27, 2023
|
|
๐ Aripiprazole is not approvable since 'major objections' have been identified
|
|
6
|
919
|
July 18, 2023
|
|
๐จ๐ญ Swissmedic creates nitrosamine expert group to coordinate with manufacturers, regulators
|
|
2
|
553
|
July 10, 2023
|
|
Ministry of Food and Drug Safety of the Republic of Korea detected N-Nitroso-Atenolol in atenolol formulation products
|
|
5
|
1195
|
May 7, 2023
|
|
The Great Nitrosamine Audit: how many more drugs will disappear from our shelves?
|
|
2
|
770
|
April 26, 2023
|
|
Nitrosamine in Antabuse
|
|
7
|
1460
|
April 18, 2023
|
|
Ascend Laboratories LLC. is voluntarily recalling Dabigatran Etcxilate Capsules due to the presence of a NDSRI, N-nitroso-dabigatran, above the established Acceptable Daily Intake (ADI) level
|
|
5
|
998
|
March 30, 2023
|
|
N-nitroso-propranolol?
|
|
18
|
2662
|
February 22, 2023
|
|
Phathom Pharmaceuticals, Inc received complete response letter from US FDA for its approved Helicobacter pylori drug products due to presence of N-nitroso-vonoprazan (NVP), nitrosamine impurity
|
|
1
|
860
|
February 10, 2023
|
|
N-nitroso-quinapril
|
|
15
|
2134
|
February 1, 2023
|
|
Merck has discovered that nitrosamine NTTP in its blockbuster diabetes medications arose mostly during storage, as well as during manufacturing and believes it can resolve the problem by the end of the year
|
|
6
|
2165
|
January 23, 2023
|
|
New NDSRIs limits coming from EMA soon
|
|
2
|
2364
|
January 16, 2023
|
|
Florida District Court dismissed claims that "Ranitidine-NDMA caused cancer -" because of "unreliable methodologies" and lacked "science-based standards"
|
|
0
|
364
|
December 13, 2022
|
|
Indian Pharmacopoeia Commission (IPC) has introduced new general chapter on (a) "Elemental Impurities" and (b) nitrosamine in Indian Pharmacopoeia (IP) 2022
|
|
4
|
1175
|
December 6, 2022
|